Ispecimen announces closing of over-allotment option in connection with its initial public offering

Lexington, mass., july 1, 2021 /prnewswire/ -- ispecimen inc. (nasdaq: ispc) ("ispecimen" or the "company"), an online marketplace for human biospecimens, today announced the closing of the issuance of an additional 337,500 shares of its common stock pursuant to the full exercise of the underwriters' over-allotment option in connection with the company's initial public offering (the "ipo").
ISPC Ratings Summary
ISPC Quant Ranking